Ledger.Open graph →
SEC Form D · filed May 2, 2024

Lexaria Bioscience Corp

Offering
$365K
Sold
$365K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KELOWNA, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Nelson Cabatuan · Kelowna, British Columbia, CanadaExecNicholas Baxter · Kelowna, British Columbia, CanadaDirectorCatherine Turkel · Kelowna, British Columbia, CanadaDirectorAlbert E. Reese · Kelowna, British Columbia, CanadaDirectorChristopher Bunka · Kelowna, British Columbia, CanadaExec · DirectorTed Mckechnie · Kelowna, British Columbia, CanadaDirectorJohn Docherty · Kelowna, British Columbia, CanadaExec · DirectorNelson Cabatuan · Kelowna, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗